Premium
Ahmadabad-based Intas Pharmaceutical Ltd has revived its IPO plan which it had deferred last year due to volatile market conditions, sources told VCCircle.The three-decade-old company, that was expecting to raise Rs 425cr ($78.7 million) in fresh capital apart from a secondary sale last year, is now planning to go public ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
